Latest Articles
-
Will AI’s Tough Economics Pop Nvidia’s Bubble?
Nvidia (NASDAQ: NVDA) stock has seen a 120% plus rally this year. With a $2.8 trillion market cap, Nvidia’s valuation is in the vicinity of tech titans Microsoft (NASDAQ:MSFT) and Apple (NASDAQ: AAPL) . Nvidia has a lot going for it as c...
-
eBay Stock Is Up 26% YTD, What To Expect From Q2 Earnings?
eBay (NASDAQ: EBAY) stock gained 26% YTD as compared to a 13% rise in the S&P500 index. Notably, eBay’s peer Amazon (NASDAQ: AMZN) is up 20% YTD. Overall, eBay is scheduled to report its fiscal Q2 2024 results on Wednesday, July 31. We ...
-
How Will DR Horton & Its Peers Handle A Weakening Housing Market?
Our theme of Housing Stocks, which includes the stocks of home improvement players, building supply companies, and home builders including DR Horton (NYSE:DHI) and Pulte Group (NYSE:PHM) has gained about 16% year-to-date. This compares to the S...
-
What’s Next For UPS Stock After A Dismal Q2?
UPS (NYSE: UPS) recently reported its Q2 results, with revenues and earnings missing the street estimates. The company reported revenue of $21.8 billion and adjusted earnings of $1.79 per share, compared to the consensus estimates of $22.2 bil...
-
What’s Next For Textron Stock After A 5% Fall In A Week?
Textron (NYSE: TXT) recently reported its Q2 results, with the top line aligning and the bottom-line exceeding our estimates . The company reported revenues of $3.5 billion and adjusted earnings of $1.54 per share, compared to our estimates of ...
-
Should You Pick RTX Corp Stock At $125 After 10% Gains In A Week?
RTX Corp stock (NYSE: RTX), formerly known as Raytheon Technologies, has seen a rise of 9% in a week, faring better than its peer — General Electric stock – up 3%. The rise in RTX stock in recent days can be attributed to the company’s upbeat Q...
-
Down 23% This Year, Will Starbucks’ Stock Recover Following Q3 Results?
[Note: Starbucks’ fiscal year 2023 ended October 1] Starbucks stock (NASDAQ: SBUX), the world’s leading roaster, marketer, and retailer of specialty coffee worldwide, is scheduled to report its Q3 2024 results on Tuesday, July 30. ...
-
Down 14% YTD, What Lies Ahead For McDonald’s Stock Following Q2 Earnings?
McDonald’s stock (NYSE: MCD), a restaurant chain consisting of more than 40,000 mostly franchised stores, is scheduled to report its fiscal second-quarter results on Monday, July 29. We expect MCD stock to likely trade higher with both re...
-
Meta Platforms Stock Is Up Twice As Much As S&P500, What To Expect From Q2 Results?
Meta Platforms (NASDAQ: META) stock gained 28% YTD, as compared to a 14% rise in the S&P500 index. Notably, Meta Platforms’ peer Alphabet (Google) (NASDAQ: GOOG) is up 20% YTD. Overall, META is scheduled to report its fiscal Q2 2024 resul...
-
Hybrids Will Drive Toyota’s Q1 Earnings
Toyota Motor Corp (NYSE:TM) stock has gained about 6% this year. In comparison, U.S. rival GM (NYSE:GM) stock has gained about 22% over the same period. Toyota is expected to publish its Q1 FY’25 earnings in early August, reporting on a ...
-
Is Eli Lilly Stock Headed Toward $1300 Levels?
Eli Lilly stock (NYSE: LLY) has seen its stock rise by around 50% this year, outperforming the broader indices, with the S&P 500 up over 15%. The stock now trades at 63x projected 2024 earnings of $13.75 per share. Does this make the stock ...
-
Will Pfizer Stock Post A Downbeat Q2?
Pfizer (NYSE: PFE) is scheduled to report its Q2 2024 results on Tuesday, July 30. We expect the company to post revenue of $12.95 billion and earnings of $0.44 on a per share and adjusted basis, lower than the consensus estimates. The company is...
-
Should You Pick Abbott Stock At $105 After A Solid Q2?
Abbott (NYSE: ABT) recently reported its Q2 results, with revenues and earnings exceeding our expectations . The company reported revenue of $10.4 billion and earnings of $1.14 on a per-share and adjusted basis, compared to our estimates of $10...
-
Is An Earnings Beat In The Cards For Merck Stock?
Merck (NYSE: MRK) will report its Q2 2024 results on Tuesday, July 30. We expect the company to post revenue of $15.9 billion and adjusted earnings of $2.20, slightly ahead of the street estimates. As usual, Keytruda will be driving the growth ...
-
Growth Portfolio Will Likely Drive Bristol Myers Squibb’s Q2
Bristol Myers Squibb (NYSE: BMY) is scheduled to report its Q2 2024 results on Friday, July 26. We expect BMY stock to trade higher, with its revenue and earnings likely exceeding the street estimates. The company should benefit from continued ...
